news 
**Injective (INJ) Gains Momentum with EVM Testnet Launch, Strategic Partnerships, and Bullish Outlook**
The recent developments in the decentralized finance (DeFi) ecosystem have been dominated by Injective’s (INJ) extraordinary performance. Over the past week, the platform has unveiled its Ethereum Virtual Machine (EVM) testnet, secured strategic partnerships with industry giants Google Cloud and Deutsche Telekom, and filed for an INJ Staked ETF to attract institutional investors.
These pivotal announcements have propelled INJ’s price above critical resistance levels, fueling a 10.71% daily gain that has catapulted the asset to $13.44. The implications of these strategic moves are far-reaching, solidifying Injective’s position as a frontrunner in real-world asset (RWA) tokenization.
**EVM Testnet Launch Drives Growth**
The launch of the EVM testnet on July 9 has fueled a 1,700% increase in daily active addresses since January, reaching over 82,000. This milestone underscores Injective’s commitment to Ethereum-based assets and its readiness for mainstream adoption. As INJ surges higher, it is crucial that traders consider long-term prospects rather than short-term gains.
**Strategic Partnerships Drive Institutional Interest**
The formation of the strategic council with Google Cloud and Deutsche Telekom has bolstered investor confidence, resulting in a 15% price surge. These partnerships will accelerate institutional adoption and innovation in DeFi, further amplifying Injective’s growth trajectory.
**INJ Staked ETF Filing Boosts Adoption Potential**
By filing for an INJ Staked ETF on July 14, Injective has opened the door to regulated staking rewards for institutional investors. This groundbreaking development bridges traditional finance and DeFi, paving the way for increased institutional capital inflow.
**Market Momentum: A Bullish Outlook**
The confluence of these strategic developments has propelled INJ above $13.50 resistance, positioning it for continued growth in the short term. While overbought conditions may lead to minor pullbacks or consolidations, the overall outlook remains bullish due to Injective’s commitment to innovation and scalability.
**Conclusion**
In conclusion, Injective’s (INJ) extraordinary growth can be attributed to its proactive approach to DeFi innovation, strategic partnerships, and regulatory clarity. As the asset continues to defy resistance levels, we expect further price action above $15.48 in the coming quarters, provided broader market conditions remain favorable.
Source: Blockchain.News
